We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Pilgrim's Pride
PPC
$7.06B
| $457K | ﹤0.01% |
16,196
+8,767
| +118% | +$249K |
|
|
HOOK
1502
DELISTED
HOOKIPA Pharma
HOOK
| $455K | ﹤0.01% |
19,536
+1,859
| +11% | +$74.7K |
|
1503
Monster Beverage
MNST
$87.3B
| $454K | ﹤0.01% |
18,888
+7,632
| +68% | +$170K |
|
1504
Quest Diagnostics
DGX
$27.3B
| $453K | ﹤0.01% |
2,613
-626
| -19% | -$95.2K |
|
1505
CMS Energy
CMS
$20.7B
| $452K | ﹤0.01% |
6,948
+474
| +7% | +$29.1K |
|
1506
DuPont de Nemours
DD
$17.2B
| $448K | ﹤0.01% |
4,423
-3,398
| -43% | -$323K |
|
1507
AtriCure
ATRC
$2.91B
| $447K | ﹤0.01% |
6,424
-4,052
| -39% | -$295K |
|
1508
California Resources
CRC
$4.84B
| $445K | ﹤0.01% |
+10,415
| New | +$446K |
|
1509
MannKind Corp
MNKD
$1.14B
| $445K | ﹤0.01% |
101,846
-96
| -0.1% | -$444 |
|
1510
GATX Corp
GATX
$6.27B
| $444K | ﹤0.01% |
4,259
+226
| +6% | +$22.5K |
|
1511
Gen Digital
GEN
$18.3B
| $444K | ﹤0.01% |
17,072
+7,271
| +74% | +$184K |
|
1512
Southwest Airlines
LUV
$19.2B
| $444K | ﹤0.01% |
10,375
+5,158
| +99% | +$242K |
|
1513
TransDigm Group
TDG
$59.7B
| $441K | ﹤0.01% |
693
+222
| +47% | +$139K |
|
|
BHVN
1514
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $438K | ﹤0.01% |
3,180
-241,146
| -99% | -$30.7M |
|
1515
ASE Group
ASX
$98.8B
| $436K | ﹤0.01% |
55,826
+6,469
| +13% | +$47.5K |
|
1516
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.2B
| $436K | ﹤0.01% |
3,290
-1,337
| -29% | -$178K |
|
1517
VICI Properties
VICI
$27B
| $434K | ﹤0.01% |
14,400
| – | – |
|
1518
International Bancshares
IBOC
$4.41B
| $433K | ﹤0.01% |
10,223
-2,458
| -19% | -$106K |
|
|
SEV
1519
DELISTED
Sono Group N.V. Common Shares
SEV
| $433K | ﹤0.01% |
+45,000
| New | +$678K |
|
1520
California Water Service
CWT
$2.97B
| $426K | ﹤0.01% |
5,926
+131
| +2% | +$8.42K |
|
1521
Inogen
INGN
$136M
| $425K | ﹤0.01% |
12,511
-173
| -1% | -$6.29K |
|
1522
Qorvo
QRVO
$10.1B
| $418K | ﹤0.01% |
2,673
+137
| +5% | +$21.8K |
|
|
HLAHW
1523
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Warrant
HLAHW
| $409K | ﹤0.01% |
676,112
| – | – |
|
1524
Asana
ASAN
$2.21B
| $408K | ﹤0.01% |
5,472
-276,240
| -98% | -$29.3M |
|
1525
Dillards
DDS
$10.1B
| $407K | ﹤0.01% |
1,658
-18,266
| -92% | -$4.81M |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.